Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., . . . Doo, E. (2014). Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial. Lancet.
シカゴスタイル引用形Neuschwander-Tetri, Brent A., et al. "Farnesoid X Nuclear Receptor Ligand Obeticholic Acid for Non-cirrhotic, Non-alcoholic Steatohepatitis (FLINT): A Multicentre, Randomised, Placebo-controlled Trial." Lancet 2014.
MLA引用形式Neuschwander-Tetri, Brent A., et al. "Farnesoid X Nuclear Receptor Ligand Obeticholic Acid for Non-cirrhotic, Non-alcoholic Steatohepatitis (FLINT): A Multicentre, Randomised, Placebo-controlled Trial." Lancet 2014.